FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SABATOLIMAB
异名/同义词ANTI-TIM3 CHECKPOINT INHIBITOR MBG453
ANTI-TIM-3 MONOCLONAL ANTIBODY MBG453
IMMUNOGLOBULIN G4 (226-PROLINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN HEPATITIS VIRUS A CELLULAR RECEPTOR 2) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS HAVCR2 (HEPATITIS A VIRUS CELLULAR RECEPTOR 2, T-CELL IMMUNOGLOBULIN MUCIN FAMILY MEMBER 3, TIM-3, TIM3, TIMD3, CD366)), HUMANIZED MONOCLONAL ANTIBODY
MBG453
MBG-453
NVP-MBG453
SABATOLIMAB
SABATOLIMAB [INN]
SABATOLIMAB [JAN]
SABATOLIMAB [USAN]
SABATOLIMAB [WHO-DD]
CAS登记号2252262-24-9
物质唯一标识(Unique Ingredient Identifier)3L7R886Y06
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 日本药品名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System